Fred Lampropoulos Net Worth

The estimated Net Worth of Fred P Lampropoulos is at least $17.2 Million dollars as of 25 August 2023. Mr. Lampropoulos owns over 206,000 units of Merit Medical Systems stock worth over $1,252,069 and over the last 24 years he sold MMSI stock worth over $10,906,220. In addition, he makes $5,049,290 as Chairman of the Board, President, and Chief Executive Officer at Merit Medical Systems.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Lampropoulos MMSI stock SEC Form 4 insiders trading

Fred has made over 25 trades of the Merit Medical Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 206,000 units of MMSI stock worth $5,809,200 on 25 August 2023.

The largest trade he's ever made was exercising 206,000 units of Merit Medical Systems stock on 25 August 2023 worth over $5,809,200. On average, Fred trades about 11,247 units every 34 days since 2000. As of 25 August 2023 he still owns at least 12,888 units of Merit Medical Systems stock.

You can see the complete history of Mr. Lampropoulos stock trades at the bottom of the page.

Fred Lampropoulos biography

Fred P. Lampropoulos serves as Chairman of the Board, President, Chief Executive Officer of the Company. He served as Chair of the Board, CEO and President of the Company since its formation in 1987 Chair of the Board and President of Utah Medical Products, Inc. (medical device manufacturer), 1983 to 1987 Filed more than 200 domestic and international patents and applications on medical devices Serves on several community and advisory boards Recipient of numerous community and industry awards, including 2003 and 2018 Utah Governor’s Medal for Science and Technology. The Board believes the Company benefits immensely from Mr. Lampropoulos’ experience as founder, President and Chief Executive Officer. He plays an essential role in communicating the expectations, advice, concerns and encouragement of the Board to our employees. Mr. Lampropoulos has a deep knowledge and understanding of the Company, as well as the industry and markets in which our products compete. Mr. Lampropoulos also performs an essential function as the Chair of the Board, providing decisive leadership and direction to the activities and deliberations of the Board. The Board also believes Mr. Lampropoulos’ leadership, drive and determination are significant factors in our growth and development and continue to be tremendous assets to the Company and its shareholders.

What is the salary of Fred Lampropoulos?

As the Chairman of the Board, President, and Chief Executive Officer of Merit Medical Systems, the total compensation of Fred Lampropoulos at Merit Medical Systems is $5,049,290. There are no executives at Merit Medical Systems getting paid more.

How old is Fred Lampropoulos?

Fred Lampropoulos is 70, he's been the Chairman of the Board, President, and Chief Executive Officer of Merit Medical Systems since 1987. There are 2 older and 14 younger executives at Merit Medical Systems. The oldest executive at Merit Medical Systems, Inc. is A. Scott Anderson, 73, who is the Independent Director.

What's Fred Lampropoulos's mailing address?

Fred's mailing address filed with the SEC is 1600 WEST MERIT PARKWAY, , SOUTH JORDAN, UT, 84095.

Insiders trading at Merit Medical Systems

Over the last 24 years, insiders at Merit Medical Systems have traded over $17,410,674 worth of Merit Medical Systems stock and bought 12,774 units worth $365,476 . The most active insiders traders include Fred P Lampropoulos, Kent W Stanger, and A Scott Anderson. On average, Merit Medical Systems executives and independent directors trade stock every 24 days with the average trade being worth of $1,968,745. The most recent stock trade was executed by F. Ann Millner on 28 June 2024, trading 12,500 units of MMSI stock currently worth $631,250.

What does Merit Medical Systems do?

merit medical systems, inc. (nasdaq: mmsi) is a leading manufacturer of medical devices used in diagnostic & interventional cardiology & radiology procedures. its primary products consist of inflation devices used in angioplasty, stent placement & discography; diagnostic & therapeutic catheters used for various procedures in cardiology & radiology; guide wires used to place balloon angioplasty catheters within a patient's coronary arteries; products used to manage & monitor the administration of contrast & other fluid solutions during diagnostic & therapeutic procedures; thrombolytic catheters & fluid dispensing systems; angiography accessories; & standard & custom angiography kits. headquartered in south jordan, utah, a suburb of salt lake city, merit employs approximately 1,900 people worldwide. merit markets its products in the united states & europe (direct sales force) & the world (distributors). they call directly on physicians & clinicians in hospitals & clinics worldwide. the c

Complete history of Mr. Lampropoulos stock trades at Merit Medical Systems

Merit Medical Systems executives and stock owners

Merit Medical Systems executives and other stock owners filed with the SEC include:

• Fred Lampropoulos,
  Chairman of the Board, President, Chief Executive Officer
• Fred P. Lampropoulos,
  Founder, Chairman, CEO & Pres
• Joseph Wright,
  President - International Division
• Ronald Frost,
  Chief Operating Officer
• Justin Lampropoulos,
  Executive Vice President - Sales, Marketing and Strategy
• Brian Lloyd,
  Chief Legal Officer, Corporate Secretary
• Raul Parra,
  Chief Financial Officer, Treasurer
• Ronald A. Frost,
  Chief Operating Officer
• Raul Parra Jr., CPA,
  CFO & Treasurer
• Brian G. Lloyd,
  Chief Legal Officer & Corp. Sec.
• Jill Anderson,
  Independent Director
• Thomas Gunderson,
  Independent Director
• A. Scott Anderson,
  Independent Director
• F. Ann Millner,
  Independent Director
• Lynne Ward,
  Director
• Anne-Marie Wright,
  Vice President - Corporate Communications
• Dr. Nicole Priest,
  Chief Wellness Officer
• Neil Peterson,
  Chief Operating Officer
• Joseph C. Wright,
  Pres of International Division
• John Knorpp,
  Chief Regulatory Affairs Officer
• Michel J. Voigt,
  Chief HR Officer
• Joseph Pierce,
  Chief Information Officer
• Jason Treft,
  Chief Technology Officer
• Franklin J Miller,
  
• Bernard Birkett,
  Chief Financial Officer
• Kent W Stanger,
  Chief Financial Officer
• Michael E Stillabower,
  Director
• Richard W Edelman,
  Director
• Silvia Perez,
  
• Elizabeth Huebner,
  Director
• Greg L Barnett,
  
• Arlin D Nelson,
  Chief Operating Officer
• Rashelle Perry,
  Chief Legal Officer
• Martin R Stephens,
  VP of Sales
• Brian L Ferrand,
  Director of Sales
• B Leigh Weintraub,
  Vice President - Operations
• Rex C Bean,
  Director
• James J Ellis,
  Director
• Laura S. Kaiser,
  
• Stephen C. Evans,
  
• Nolan E. Karras,
  
• David Ming Teh Liu,
  
• Lonny J Carpenter,
  
• David Floyd,
  
• James T. Hogan,
  
• Michel James Voigt,
  CHIEF HUMAN RESOURCES OFFICER
• Michael R Mcdonnell,
  
• Neil Peterson,
  CHIEF OPERATING OFFICER